Skip to main content

Manohar Furtado

LexaGene has appointed Manohar Furtado to its board of directors. With over 30 years of experience in the life science industry, Furtado has worked in discovery research, clinical diagnostic testing, product development and commercialization, M&A activity, fundraising, and strategy. He currently serves as president and founder of Biology for Global Good and CSO and chief regulatory officer at Apton Biosystems. Prior to Biology for Global Good, he served as VP of R&D at Applied Biosystems.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.